Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients

Table 1 Seroprevalence of HBsAg and anti HCV antibodies in HIV positive patients

	HBsAg	HCV
HIV patients (n = 451)	24 (5.32)b	11 (2.43)a
Males (n = 345)	23 (6.6)	6 (1.7)
Females (n = 106)	1 (0.94)	5 (4.7)
Controls (n = 428)	6 (1.4)	3 (0.7)
Males (n = 259)	4 (1.5)	2 (0.7)
Females (n = 169)	2 (1.1)	1 (0.59)

Values in parenthesis are percentages. Control group includes HIV negative healthy donors.

^aP < 0.05,

^bP < 0.001 vs controls.